Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid.
M J Liu, G M Pollack
Index: Biopharm. Drug Dispos. 14(4) , 325-39, (1993)
Full Text: HTML
Abstract
The pharmacokinetics of valproic acid (VPA) and three structural analogs, octanoic acid (OA), cyclohexanecarboxylic acid (CCA), and 1-methyl-1-cyclohexanecarboxylic acid (MCCA), were examined in female Sprague-Dawley rats. All four carboxylic acids evidenced dose-dependent disposition. A dose-related decrease in total body clearance was observed for each test compound, suggesting the presence of saturable elimination processes. Furthermore, the apparent volume of distribution for these compounds was, with the exception of CCA, dose-dependent, indicating that binding to proteins in serum and/or tissues may be saturable. Both VPA and MCCA exhibited enterohepatic recirculation, although the degree of recirculation appeared to be dose- and compound-dependent. Significant quantities of both VPA and MCCA were excreted in the urine as base-labile conjugates, presumably representing glucuronides. In contrast, OA and CCA were not excreted in the urine as base-labile conjugates and did not evidence enterohepatic recirculation. CCA displayed apparent Michaelis-Menten kinetics, although the calculated Km was dose-dependent. The results suggest that relatively minor changes in chemical structure have a marked influence on the metabolism and disposition of low molecular weight carboxylic acids.
Related Compounds
Related Articles:
Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acid.
1997-11-01
[J. Pharmacol. Exp. Ther. 283(2) , 698-703, (1997)]
1984-01-01
[J. Biol. Response Mod. 3(2) , 132-7, (1984)]
[A method for determining arsenic in biological material].
1992-01-01
[Sud. Med. Ekspert. 35(1) , 31-2, (1992)]
1994-01-01
[Epilepsia 35(1) , 234-43, (1994)]
Regulation of c- and N-myc expression during induced differentiation of murine neuroblastoma cells.
1991-04-01
[Oncogene 6(4) , 633-8, (1991)]